Klinische FragestellungMorbus Huntington-ähnliche Krankheit 1, Differentialdiagnose
Zusammenfassung
Kurzinformation
Umfassendes differentialdiagnostisches panel für Morbus Huntington-ähnliche Krankheit 1 mit 7 Leitlinien-kuratierten bzw. zusammen genommen 25 kuratierten Genen gemäß klinischer Verdachtsdiagnose
ID
MP1779
Anzahl Gene
25
Akkreditierte Untersuchung
Untersuchte Sequenzlänge
19,5 kb (Core-/Core-canditate-Gene)
52,0 kb (Erweitertes Panel: inkl. additional genes)
52,0 kb (Erweitertes Panel: inkl. additional genes)
Analyse-Dauer
auf Anfrage
Untersuchungsmaterial
- EDTA-Blut (3-5 ml)
Diagnostische Hinweise
NGS +
X
Genpanel
Ausgewählte Gene
Name | Exon-Länge (bp) | OMIM-G | Referenz-Seq. | Erbgang |
---|---|---|---|---|
ATXN2 | 3462 | NM_002973.4 | AD | |
ATXN3 | 1086 | NM_004993.6 | AD | |
ATXN7 | 2679 | NM_000333.4 | AD | |
C9orf72 | 1446 | NM_018325.5 | AD | |
HTT | 9429 | NM_002111.8 | AD | |
JPH3 | 561 | NM_001271604.4 | AD | |
PRNP | 762 | NM_000311.5 | AD | |
APP | 2313 | NM_000484.4 | AD | |
ATXN1 | 2448 | NM_000332.3 | AD | |
CACNA1A | 6786 | NM_001127221.2 | AD | |
CHMP2B | 642 | NM_014043.4 | AD | |
CSF1R | 2919 | NM_005211.4 | AD | |
FUS | 1581 | NM_004960.4 | AD | |
GBA1 | 1611 | NM_001005741.3 | AD | |
GRN | 1782 | NM_002087.4 | AD | |
HNRNPA1 | 1119 | NM_031157.4 | AD | |
HNRNPA2B1 | 1026 | NM_002137.4 | AD | |
MAPT | 1326 | NM_005910.6 | AD | |
PANK2 | 1713 | NM_153638.4 | AR | |
PSEN1 | 1404 | NM_000021.4 | AD | |
PSEN2 | 1347 | NM_000447.3 | AD | |
SNCA | 423 | NM_000345.4 | AD | |
SNCB | 405 | NM_001001502.3 | AD | |
TARDBP | 1245 | NM_007375.4 | AD | |
VCP | 2421 | NM_007126.5 | AD |
Infos zur Erkrankung
Synonyme
- Genetic prion disease: Creutzfeldt-Jakob d., fatal fam. insomnia, Gerstmann-Sträussler-Scheinker s.
- Alias: Chorea Huntington-ähnliche Krankheit 1
- Alias: Early-onset prion disease with prominent psychiatric features
- Alias: Früh-einsetzende Prionkrankheit mit prominenten psychiatrischen Merkmalen
- Alias: Huntington disease-like 1
- Allelic: Lopes-Maciel-Rodan syndrome (HTT)
- Alzheimer disease 1, familial (APP)
- Alzheimer disease, type 3 (PSEN1)
- Alzheimer disease, type 3, with spastic paraparesis + apraxia (PSEN1)
- Alzheimer disease, type 3, with spastic paraparesis + unusual plaques (PSEN1)
- Alzheimer disease-4 (PSEN2)
- Amyotrophic lateral sclerosis 10, with/-out FTD (TARDBP)
- Amyotrophic lateral sclerosis 20 (HNRNPA1)
- Amyotrophic lateral sclerosis 6, with/-out frontotemporal dementia (FUS)
- Aphasia, primary progressive (GRN)
- Brain abnormalities, neurodegeneration + dysosteosclerosis (CSF1R)
- Cerebral amyloid angiopathy, Dutch, Italian, Iowa, Flemish, Arctic variants (APP)
- Cerebral amyloid angiopathy, PRNP-related (PRNP)
- Ceroid lipofuscinosis, neuronal, 11 (GRN)
- Creutzfeldt-Jakob disease (PRNP)
- Dementia, Lewy body (SNCA, SNCB)
- Dementia, frontotemporal (PSEN1)
- Dementia, frontotemporal, with/-out parkinsonism (MAPT)
- Developmental + epileptic encephalopathy 42 (CACNA1A)
- Episodic ataxia, type 2 (CACNA1A)
- Frontotemporal dementia and/or amyotrophic lateral sclerosis 1 (C9orf72_GGGGCC)
- Frontotemporal dementia and/or amyotrophic lateral sclerosis 6 (VCP)
- Frontotemporal dementia and/or amyotrophic lateral sclerosis 7 (CHMP2B)
- Frontotemporal lobar degeneration with ubiquitin-positive inclusions (GRN)
- Frontotemporal lobar degeneration, TARDBP-related (TARDBP)
- Gaucher disease, perinatal lethal (GBA)
- Gaucher disease, type I, II, III, IIIC (GBA)
- Gerstmann-Straussler disease (PRNP)
- HARP syndrome [Hypoprebetalipoproteinemia, Acanthocytosis, Retinitis pigm., Pallidal degen.] (PANK2)
- Huntington disease (HTT_CAG)
- Huntington disease-like 1 (PRNP)
- Huntington disease-like 2 (JPH3_CTG)
- Inclusion body myopathy + early-onset Paget dis. no frontotemporal dementia 3 (HNRNPA1)
- Inclusion body myopathy + early-onset Paget dis. with/-out frontotemporal dementia 2 (HNRNPA2B1)
- Inclusion body myopathy with early-onset Paget disease + frontotemporal dementia 1 (VCP)
- Insomnia, fatal familial (PRNP)
- Kuru, susceptibility to (PRNP)
- Leukoencephalopathy, diffuse hereditary, with spheroids (CSF1R)
- Lewy body dementia, susceptibility to (GBA)
- Machado-Joseph disease (ATXN3_CAG)
- Migraine, familial hemiplegic, 1 (CACNA1A)
- Migraine, familial hemiplegic, 1, with progressive cerebellar ataxia (CACNA1A)
- Neurodegeneration with brain iron accumulation 1 (PANK2)
- Pick disease (MAPT)
- Pick disease (PSEN1)
- Spinocerebellar ataxia 1 (ATXN1_CAG)
- Spinocerebellar ataxia 2 (ATXN2_CAG)
- Spinocerebellar ataxia 6 (CACNA1A_CAG)
- Spinocerebellar ataxia 7 (ATXN7_CAG)
- Spongiform encephalopathy with neuropsychiatric features (PRNP)
- Supranuclear palsy, progressive (MAPT)
- Supranuclear palsy, progressive atypical (MAPT)
Erbgänge, Vererbungsmuster etc.
- AD
- AR
OMIM-Ps
- Multiple OMIM-Ps
ICD10 Code
Bioinformatik und klinische Interpretation
Kein Text hinterlegt